share_log

Earnings Beat: Bath & Body Works, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Earnings Beat: Bath & Body Works, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

盈利快报:Bath & Body Works, Inc.刚刚超过了分析师的预期,分析师一直在更新他们的模型
Simply Wall St ·  03/03 08:28

Shareholders might have noticed that Bath & Body Works, Inc. (NYSE:BBWI) filed its full-year result this time last week. The early response was not positive, with shares down 3.3% to US$45.68 in the past week. It looks like a credible result overall - although revenues of US$7.4b were what the analysts expected, Bath & Body Works surprised by delivering a (statutory) profit of US$3.84 per share, an impressive 24% above what was forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

股东们可能已经注意到,Bath & Body Works, Inc.(纽约证券交易所代码:BBWI)上周这个时候公布了全年业绩。早期的反应并不乐观,过去一周股价下跌3.3%,至45.68美元。总体而言,这似乎是一个可信的业绩——尽管分析师预期的收入为74亿美元,但Bath & Body Works出人意料地实现了每股3.84美元的(法定)利润,比预期高出24%。根据结果,分析师更新了他们的盈利模式,很高兴知道他们是否认为公司的前景发生了巨大变化,或者业务是否照旧。考虑到这一点,我们收集了最新的法定预测,以了解分析师对明年的预期。

earnings-and-revenue-growth
NYSE:BBWI Earnings and Revenue Growth March 3rd 2024
纽约证券交易所:BBWI 收益和收入增长 2024 年 3 月 3 日

Taking into account the latest results, Bath & Body Works' 19 analysts currently expect revenues in 2025 to be US$7.42b, approximately in line with the last 12 months. Statutory earnings per share are forecast to sink 15% to US$3.32 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$7.44b and earnings per share (EPS) of US$3.39 in 2025. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

考虑到最新业绩,Bath & Body Works的19位分析师目前预计,2025年的收入将达到74.2亿美元,与过去12个月大致持平。预计同期每股法定收益将下降15%,至3.32美元。然而,在最新财报公布之前,分析师曾预计2025年收入为74.4亿美元,每股收益(EPS)为3.39美元。鉴于明年每股收益略有下降,分析师在最新业绩公布后似乎对该业务变得更加消极了。

Despite cutting their earnings forecasts,the analysts have lifted their price target 8.7% to US$50.43, suggesting that these impacts are not expected to weigh on the stock's value in the long term. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Bath & Body Works, with the most bullish analyst valuing it at US$78.00 and the most bearish at US$40.00 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

尽管下调了收益预期,但分析师仍将目标股价上调了8.7%,至50.43美元,这表明从长远来看,这些影响预计不会打压该股的价值。研究分析师的估计范围,评估异常值与平均值的差异程度也可能很有启发性。对Bath & Body Works的看法有所不同,最看涨的分析师将其估值为78.00美元,最看跌的为每股40.00美元。注意到分析师目标股价的巨大差距了吗?对我们来说,这意味着基础业务存在相当广泛的可能情景。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would also point out that the forecast 0.2% annualised revenue decline to the end of 2025 is better than the historical trend, which saw revenues shrink 12% annually over the past five years By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 5.2% per year. So while a broad number of companies are forecast to grow, unfortunately Bath & Body Works is expected to see its revenue affected worse than other companies in the industry.

从现在的大局来看,我们可以理解这些预测的方法之一是看看它们如何与过去的业绩和行业增长预期相比较。我们还要指出,到2025年底,预计年化收入下降0.2%,好于历史趋势,在过去五年中,收入每年下降12%。相比之下,我们的数据表明,类似行业的其他公司(有分析师的报道)的收入预计将每年增长5.2%。因此,尽管预计将有许多公司增长,但不幸的是,预计Bath & Body Works的收入将比业内其他公司受到的影响更严重。

The Bottom Line

底线

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Bath & Body Works. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Bath & Body Works' revenue is expected to perform worse than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

最大的担忧是,分析师下调了每股收益预期,这表明Bath & Body Works可能会面临业务不利因素。幸运的是,分析师还重申了他们的收入预期,表明收入符合预期。尽管我们的数据确实表明,预计Bath & Body Works的收入表现将低于整个行业。我们注意到目标股价已上调,这表明分析师认为该业务的内在价值可能会随着时间的推移而提高。

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Bath & Body Works going out to 2027, and you can see them free on our platform here.

考虑到这一点,我们仍然认为该业务的长期发展轨迹对于投资者来说更为重要。我们对Bath & Body Works的预测将持续到2027年,你可以在我们的平台上免费查看。

Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Bath & Body Works (1 can't be ignored) you should be aware of.

别忘了可能仍然存在风险。例如,我们已经确定了 Bath & Body Works 的 3 个警告标志(1 个不容忽视),你应该注意。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发